reference/33916020

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33916020

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
issn	2041-4889
issueIdentifier	5
pageRange	450-
publicationName	Cell Death & Disease
startingPage	450
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a94dec2bf8b9ac8e3b7a26db64dbea61 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4d0b9f77b45ccd2c7ef27f564f1cfe57 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b6e34b2a0386ebe91db2349b879352f2 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
bibliographicCitation	Sun H, Zheng J, Xiao J, Yue J, Shi Z, Xuan Z, Chen C, Zhao Y, Tang W, Ye S, Li J, Deng Q, Zhang L, Zhu F, Shao C. TOPK/PBK is phosphorylated by ERK2 at serine 32, promotes tumorigenesis and is involved in sorafenib resistance in RCC. Cell Death & Disease. 2022 May 11;13(5):450. doi: 10.1038/s41419-022-04909-3.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3dcb22f0e2971d11eb24050703b73e69 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e659e70f32a94d5dab44a36f9e0ef203 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a1e2a30d6dddab467f017a35c934447f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_23cae52cc4e902b91ab5d540cba13ba7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f286d57cdaf783681b08ca853fb47162 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_436807d09284343cbd1c077bae449f11 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b675543c31ad23cf31bd249461a8bdb9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_24841704ce81c8e292afd3bcc59a18a9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f0947df4a17a8463cdeb590de6d073e9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3c949f7b94f75706d697890d709324fc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fbd90e929fefcb072f914932ea1bf92e http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6818-6660 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_739e4f70e037ad9df13963db0b775c92 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2892-5596 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4e39e0249229958306826e51cd4fb207
date	2022-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC9095598 https://doi.org/10.1038/s41419-022-04909-3 https://pubmed.ncbi.nlm.nih.gov/35546143
isPartOf	https://portal.issn.org/resource/ISSN/2041-4889 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37956
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	TOPK/PBK is phosphorylated by ERK2 at serine 32, promotes tumorigenesis and is involved in sorafenib resistance in RCC
discusses	http://id.nlm.nih.gov/mesh/M0446095 http://id.nlm.nih.gov/mesh/M0029623 http://id.nlm.nih.gov/mesh/M0019675 http://id.nlm.nih.gov/mesh/M0529566 http://id.nlm.nih.gov/mesh/M0363871 http://id.nlm.nih.gov/mesh/M0328038
hasSubjectTerm	http://purl.org/au-research/vocabulary/anzsrc-for/2008/06 http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23694678 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7170 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e64b5f8a4c9c61082b4d0780664c293f http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3d628a25e892b9935143372f9882c544 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216239 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5951 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ae6e03cbecb7de45c19d24596aa66cd1 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d187535d40b96a60387e8dff44b0c491 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c4c4909eaa4fc41a39f0fa5c96f30cd6

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5594 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID55872

Total number of triples: 58.